{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:14:15Z","timestamp":1792412055355,"version":"4.4.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Chronic kidney disease (CKD) is an irreversible and progressive kidney disease with a significant global health impact. Sarcopenia is an age-related syndrome characterized by the progressive loss of skeletal muscle mass and strength, and it exhibits a high prevalence, particularly among the elderly. There is a growing body of evidence indicating a strong bidirectional association between CKD and Sarcopenia. The prevalence of sarcopenia is significantly higher in CKD patients and increases as kidney function deteriorates. This review examines the potential relationship between CKD and sarcopenia, discusses their pathophysiological mechanisms, including chronic inflammation, oxidative stress, uremic toxin accumulation, metabolic acidosis, and hormonal disorders, and explores their clinical implications. Additionally, this review aims to elucidate potential pathogenic mechanisms and propose preventive and therapeutic strategies for CKD and sarcopenia, thereby guiding the optimization of clinical management and slowing disease progression.<\/jats:p>","DOI":"10.3389\/fnut.2025.1699218","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:46:41Z","timestamp":1762249601000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between chronic kidney disease and sarcopenia and emerging treatment strategies"],"prefix":"10.3389","volume":"12","author":[{"given":"Shuxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e0264393","DOI":"10.1371\/journal.pone.0264393","article-title":"Prevalence of chronic kidney disease stages 3-5 in low- and middle-income countries in Asia: a systematic review and meta-analysis","volume":"17","author":"Suriyong","year":"2022","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0292646","DOI":"10.1371\/journal.pone.0292646","article-title":"Association between systemic immune-inflammation index and chronic kidney disease: a population-based study","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"15266","DOI":"10.3390\/ijerph192215266","article-title":"Assessment of health-related quality of life, medication adherence, and prevalence of depression in kidney failure patients","volume":"19","author":"Butt","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2022.06.003","article-title":"Potential contribution of the immune system to the emergence of renal diseases","volume":"248","author":"Ghassabi","year":"2022","journal-title":"Immunol Lett"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13063-024-08509-8","article-title":"Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (prepare for kidney care): study protocol for a randomised controlled trial","volume":"25","author":"Worthington","year":"2024","journal-title":"Trials"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12882-022-02794-8","article-title":"Targeting inflammation for the treatment of diabetic kidney disease: a five-compartment mechanistic model","volume":"23","author":"Hofherr","year":"2022","journal-title":"BMC Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.ekir.2020.09.040","article-title":"Worldwide disparity in the relation between CKD prevalence and kidney failure risk","volume":"5","author":"van Rijn","year":"2020","journal-title":"Kidney Int Rep."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ageing\/afac157","article-title":"Ageing meets kidney disease","volume":"51","author":"Ortiz","year":"2022","journal-title":"Age Ageing"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"140520","DOI":"10.1016\/j.ijbiomac.2025.140520","article-title":"Urine collection by sodium alginate\/CMC composite self-calibrating aerogel SERS platform for accurate screening and staging of chronic kidney disease","volume":"302","author":"Wang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European renal and cardiovascular medicine working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ekir.2022.06.015","article-title":"Living well with kidney disease and effective symptom management: consensus conference proceedings","volume":"7","author":"Rhee","year":"2022","journal-title":"Kidney Int Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.4103\/ijpc.ijpc_69_21","article-title":"Symptom management among patients with chronic kidney disease","volume":"27","author":"Rao","year":"2021","journal-title":"Indian J Palliat Care"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41581-021-00518-z","article-title":"Patient-centred approaches for the management of unpleasant symptoms in kidney disease","volume":"18","author":"Kalantar-Zadeh","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2213-8587(17)30183-3","article-title":"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data","volume":"5","author":"Matsushita","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11255-022-03442-8","article-title":"The impact of renal transplantation on sexual function in males with end-stage kidney disease: a systematic review and meta-analysis","volume":"55","author":"Miron","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.semnephrol.2021.03.006","article-title":"Testosterone disorders and male hypogonadism in kidney disease","volume":"41","author":"Garibotto","year":"2021","journal-title":"Semin Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.semnephrol.2021.03.012","article-title":"The interplay between nutrition, metabolic, and endocrine disorders in chronic kidney disease","volume":"41","author":"Mahmoud","year":"2021","journal-title":"Semin Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.kint.2023.05.009","article-title":"Novel anemia therapies in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"104","author":"Ku","year":"2023","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European calcified tissue society and the European renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10741-023-10376-5","article-title":"Echocardiographic manifestations in end-stage renal disease","volume":"29","author":"Ito","year":"2024","journal-title":"Heart Fail Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/IJNRD.S271619","article-title":"Symptom clusters in patients with end-stage renal disease undergoing hemodialysis","volume":"13","author":"Chaiviboontham","year":"2020","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s40520-016-0589-3","article-title":"The role of DXA in sarcopenia","volume":"28","author":"Guglielmi","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"afac220","DOI":"10.1093\/ageing\/afac220","article-title":"Sarcopenia definition, diagnosis and treatment: consensus is growing","volume":"51","author":"Sayer","year":"2022","journal-title":"Age Ageing"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000448247","article-title":"Oral drugs related with muscle wasting and sarcopenia. A review","volume":"99","author":"Campins","year":"2017","journal-title":"Pharmacology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/PHM.0000000000001429","article-title":"Maintaining muscle function across the lifespan: the state of science","volume":"99","author":"Arnold","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"19099","DOI":"10.1038\/s41598-025-04331-7","article-title":"CD9, a novel potential biomarker of sarcopenia","volume":"15","author":"Yin","year":"2025","journal-title":"Sci Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3390\/cells12222608","article-title":"Age is just a number: Progress and obstacles in the discovery of new candidate drugs for sarcopenia","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/gerona\/glac139","article-title":"Age-related changes in skeletal muscle Iron homeostasis","volume":"78","author":"Alves","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/nu16030436","article-title":"Diagnostic criteria and measurement techniques of sarcopenia: a critical evaluation of the up-to-date evidence","volume":"16","author":"Voulgaridou","year":"2024","journal-title":"Nutrients"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"101200","DOI":"10.1016\/j.arr.2020.101200","article-title":"Sarcopenia- molecular mechanisms and open questions","volume":"65","author":"Wiedmer","year":"2021","journal-title":"Ageing Res Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3904\/kjim.2016.193","article-title":"Sarcopenia and sarcopenic obesity","volume":"31","author":"Choi","year":"2016","journal-title":"Korean J Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12906-024-04723-8","article-title":"Electroacupuncture treatment for sarcopenia: study protocol for a randomized controlled trial","volume":"24","author":"Li","year":"2024","journal-title":"BMC Complement Med Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e28787","DOI":"10.7759\/cureus.28787","article-title":"Sarcopenia and endocrine ageing: are they related?","volume":"14","author":"Gupta","year":"2022","journal-title":"Cureus"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3389\/fphys.2018.01883","article-title":"Mitochondria as a target for mitigating sarcopenia","volume":"9","author":"Coen","year":"2018","journal-title":"Front Physiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.15197","article-title":"MicroRNA regulatory networks in the pathogenesis of sarcopenia","volume":"24","author":"Yin","year":"2020","journal-title":"J Cell Mol Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CIA.S516704","article-title":"Molecular and cellular mechanisms linking chronic kidney disease and sarcopenia in aging: An integrated perspective","volume":"20","author":"Chang","year":"2025","journal-title":"Clin Interv Aging"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/toxins14100660","article-title":"Indoxyl sulfate might play a role in sarcopenia, while myostatin is an indicator of muscle mass in patients with chronic kidney disease: analysis from the RECOVERY study","volume":"14","author":"Lee","year":"2022","journal-title":"Toxins"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/ijn.ijn_445_21","article-title":"Uremic Sarcopenia","volume":"32","author":"Mohanasundaram","year":"2022","journal-title":"Indian J Nephrol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/jcsm.12705","article-title":"Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK biobank study","volume":"12","author":"Wilkinson","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"963913","DOI":"10.3389\/fpubh.2022.963913","article-title":"Different stages of chronic kidney disease are associated with physical performance in adults over 60 years","volume":"10","author":"Song","year":"2022","journal-title":"Front Public Health"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.13425","article-title":"Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis","volume":"15","author":"Duarte","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12877-024-04691-1","article-title":"Association between sarcopenia and new-onset chronic kidney disease among middle-aged and elder adults: findings from the China health and retirement longitudinal study","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Geriatr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1017\/S0007114523002313","article-title":"Association of sarcopenia with rapid kidney function decline and chronic kidney disease in adults with normal kidney function","volume":"131","author":"Zheng","year":"2024","journal-title":"Br J Nutr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/07435800.2024.2353842","article-title":"Possible sarcopenia and risk of chronic kidney disease: a four-year follow-up study and Mendelian randomization analysis","volume":"49","author":"Xiong","year":"2024","journal-title":"Endocr Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/ndt\/gfad243","article-title":"Sarcopenia and mild kidney dysfunction and risk of all-cause and cause-specific mortality in older adults","volume":"39","author":"Wu","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40520-025-03003-w","article-title":"Association between the coexistence of chronic kidney disease and sarcopenia with cardiovascular disease and mortality","volume":"37","author":"Jiang","year":"2025","journal-title":"Aging Clin Exp Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.3390\/nu14194077","article-title":"Prevalence of sarcopenia and its impact on cardiovascular events and mortality among Dialysis patients: a systematic review and Meta-analysis","volume":"14","author":"Wathanavasin","year":"2022","journal-title":"Nutrients"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11255-022-03291-5","article-title":"Could sarcopenia-related mortality in end-stage renal disease be underpinned by the number of hospitalizations and cardiovascular diseases?","volume":"55","author":"de Luca Corr\u00eaa","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.clnu.2022.03.025","article-title":"Association between sarcopenia and clinical outcomes in chronic kidney disease patients: a systematic review and meta-analysis","volume":"41","author":"Ribeiro","year":"2022","journal-title":"Clin Nutr"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/sdi.12686","article-title":"Does inflammation affect outcomes in dialysis patients?","volume":"31","author":"Nowak","year":"2018","journal-title":"Semin Dial"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3390\/cells9092005","article-title":"IL-1\u03b2 and TNF-\u03b1 modulation of proliferated and committed myoblasts: IL-6 and COX-2-derived prostaglandins as key actors in the mechanisms involved","volume":"9","author":"Alvarez","year":"2020","journal-title":"Cells"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e12828","DOI":"10.1111\/acel.12828","article-title":"Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers","volume":"17","author":"Wang","year":"2018","journal-title":"Aging Cell"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","article-title":"NF-kB and inflammatory cytokine Signalling: role in skeletal muscle atrophy","volume":"1088","author":"Thoma","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bbrc.2021.09.067","article-title":"Tumor necrosis factor alpha regulates myogenesis to inhibit differentiation and promote proliferation in satellite cells","volume":"580","author":"Shirakawa","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbagen.2017.12.015","article-title":"S-allyl cysteine inhibits TNF\u03b1-induced skeletal muscle wasting through suppressing proteolysis and expression of inflammatory molecules","volume":"1862","author":"Dutt","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-023-01365-6","article-title":"TNF-\u03b1 contributes to sarcopenia through caspase-8\/caspase-3\/GSDME-mediated pyroptosis","volume":"9","author":"Wu","year":"2023","journal-title":"Cell Death Discov"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/biomedicines13020352","article-title":"Sarcopenia in chronic kidney disease: a narrative review from pathophysiology to therapeutic approaches","volume":"13","author":"Tsai","year":"2025","journal-title":"Biomedicine"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"964130","DOI":"10.3389\/fcell.2022.964130","article-title":"Skeletal muscle oxidative stress and inflammation in aging: focus on antioxidant and anti-inflammatory therapy","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","article-title":"Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass","volume":"18","author":"Zhang","year":"2013","journal-title":"Cell Metab"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"155577","DOI":"10.1016\/j.cyto.2021.155577","article-title":"Therapeutic targeting of IL-6 trans-signaling","volume":"144","author":"Rose-John","year":"2021","journal-title":"Cytokine"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.24976\/Discov.Med.202436181.38","article-title":"IGF-1 regulates skeletal muscle degradation and remolding in ventilator-induced diaphragmatic dysfunction by mediating FOXO1 expression","volume":"36","author":"Yang","year":"2024","journal-title":"Discov Med"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1681\/ASN.2004100842","article-title":"Chronic kidney disease causes defects in signaling through the insulin receptor substrate\/phosphatidylinositol 3-kinase\/Akt pathway: implications for muscle atrophy","volume":"17","author":"Bailey","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/JCI118499","article-title":"Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect","volume":"97","author":"Ding","year":"1996","journal-title":"J Clin Invest"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/antiox10060936","article-title":"Indoxyl-sulfate-induced redox imbalance in chronic kidney disease","volume":"10","author":"Lu","year":"2021","journal-title":"Antioxidants"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cbi.2019.02.023","article-title":"Indoxyl sulfate induces myotube atrophy by ROS-ERK and JNK-MAFbx cascades","volume":"304","author":"Changchien","year":"2019","journal-title":"Chem Biol Interact"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"602.","DOI":"10.3390\/antiox12030602","article-title":"Mitochondrial oxidative stress and Mitophagy activation contribute to TNF-dependent impairment of Myogenesis","volume":"12","author":"Chernyavskij","year":"2023","journal-title":"Antioxidants"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41598-020-79186-1","article-title":"Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis","volume":"11","author":"Alcalde-Est\u00e9vez","year":"2021","journal-title":"Sci Rep"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14283\/jfa.2017.33","article-title":"The vicious cycle of Myostatin signaling in Sarcopenic obesity: Myostatin role in skeletal muscle growth, insulin signaling and implications for clinical trials","volume":"7","author":"Consitt","year":"2018","journal-title":"J Frailty Aging"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"36618","DOI":"10.1038\/srep36618","article-title":"Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease","volume":"6","author":"Sato","year":"2016","journal-title":"Sci Rep"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1053\/j.ackd.2022.04.009","article-title":"Acid-mediated kidney injury across the Spectrum of metabolic acidosis","volume":"29","author":"Ravikumar","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ackd.2022.04.010","article-title":"Clinical consequences of metabolic acidosis-muscle","volume":"29","author":"Ho","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MNH.0000000000000700","article-title":"New insights into muscle function in chronic kidney disease and metabolic acidosis","volume":"30","author":"Chalupsky","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/nu17030404","article-title":"Dietary patterns, kidney function, and sarcopenia in chronic kidney disease","volume":"17","author":"Kim","year":"2025","journal-title":"Nutrients"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.kint.2016.03.003","article-title":"In experimental chronic kidney disease or cancer, parathyroid hormone is a novel mediator of cachexia","volume":"89","author":"Wyatt","year":"2016","journal-title":"Kidney Int"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/jcsm.12839","article-title":"Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?","volume":"12","author":"Gungor","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000539489","article-title":"Pathophysiology of physical exercise in kidney patients: unveiling new players- the role of Myokines","volume":"49","author":"Picciotto","year":"2024","journal-title":"Kidney Blood Press Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"25 (10)","DOI":"10.3390\/ijms25105117","article-title":"Skeletal muscle injury in chronic kidney disease-from histologic changes to molecular mechanisms and to novel therapies","volume":"25","author":"Heitman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.nut.2018.12.005","article-title":"Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy","volume":"62","author":"Lai","year":"2019","journal-title":"Nutrition"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"e72510","DOI":"10.7759\/cureus.72510","article-title":"Intact parathyroid hormone (iPTH) assay: an early approach for bone health assessment in chronic renal failure","volume":"16","author":"Kumari","year":"2024","journal-title":"Cureus"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/nu14091817","article-title":"The effect of non-pharmacological and pharmacological interventions on measures associated with sarcopenia in end-stage kidney disease: a systematic review and Meta-analysis","volume":"14","author":"March","year":"2022","journal-title":"Nutrients"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1744-9987.14076","article-title":"Effect of intradialytic weight resistance training exercise in sarcopenic hemodialysis patients: a randomized controlled trial","volume":"28","author":"Chaovarin","year":"2024","journal-title":"Ther Apher Dial"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s11255-021-02799-6","article-title":"Effects of pre-dialysis resistance training on sarcopenia, inflammatory profile, and anemia biomarkers in older community-dwelling patients with chronic kidney disease: a randomized controlled trial","volume":"53","author":"Gadelha","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"435","DOI":"10.12965\/jer.2142616.308","article-title":"Steady exercise improves hand grip and leg muscle strength in hemodialysis patients","volume":"17","author":"Cha","year":"2021","journal-title":"J Exerc Rehabil"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00223-021-00898-1","article-title":"Sarcopenia in chronic kidney disease: a scoping review of prevalence, risk factors, association with outcomes, and treatment","volume":"110","author":"Chatzipetrou","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/jcsm.12791","article-title":"Resistance exercise and nutritional interventions for augmenting sarcopenia outcomes in chronic kidney disease: a narrative review","volume":"12","author":"Noor","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ndt\/gfz210","article-title":"Muscle mass and plasma myostatin after exercise training: a substudy of renal exercise (RENEXC)-a randomized controlled trial","volume":"36","author":"Zhou","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"310","DOI":"10.34067\/KID.0000000000000364","article-title":"Nutrition Management in Geriatric Patients with CKD","volume":"5","author":"Ertuglu","year":"2024","journal-title":"Kidney360"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000504240","article-title":"A practical approach to nutrition, protein-energy wasting, sarcopenia, and Cachexia in patients with chronic kidney disease","volume":"49","author":"Hanna","year":"2020","journal-title":"Blood Purif"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"288","DOI":"10.23876\/j.krcp.23.146","article-title":"Efficacy of intradialytic neuromuscular electrical stimulation and oral nutritional supplementation in hemodialysis patients: a multicenter, randomized controlled trial","volume":"44","author":"Park","year":"2025","journal-title":"Kidney Res Clin Pract."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3390\/nu15143107","article-title":"Nutritional strategies to prevent muscle loss and sarcopenia in chronic kidney disease: what do we currently know?","volume":"15","author":"Massini","year":"2023","journal-title":"Nutrients"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/09287329241291370","article-title":"Nutritional counseling's impact on muscle mass and quality of life in stage 4 chronic kidney disease malnourished patients","volume":"33","author":"Sun","year":"2025","journal-title":"Technol Health Care"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11346","article-title":"Does lower dietary protein intake result in lower muscle mass in patients with end-stage kidney failure treated by peritoneal dialysis? A retrospective study","author":"Davenport","year":"2025","journal-title":"Nutr Clin Pract"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nefroe.2018.11.007","article-title":"Influence of dietary protein intake on body composition in chronic kidney disease patients in stages 3-5: a cross-sectional study","volume":"38","author":"Barril","year":"2018","journal-title":"Nefrologia"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MCO.0000000000000871","article-title":"Sarcopenia and sarcopenic obesity in chronic kidney disease: update on prevalence, outcomes, risk factors and nutrition treatment","volume":"25","author":"Barreto Silva","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/MNH.0000000000000318","article-title":"Clinical relevance of sarcopenia in chronic kidney disease","volume":"26","author":"Moorthi","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1069651","DOI":"10.3389\/fnut.2023.1069651","article-title":"Leucine-enriched amino acid supplementation and exercise to prevent sarcopenia in patients on hemodialysis: a single-arm pilot study","volume":"10","author":"Ju","year":"2023","journal-title":"Front Nutr"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/17474124.2021.1829470","article-title":"The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease","volume":"15","author":"Dos Santos","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ggi.13547","article-title":"Effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation: a multicenter randomized controlled trial","volume":"19","author":"Takeuchi","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s11255-025-04560-9","article-title":"Anti-sarcopenic effect of leucine-enriched branched-chain amino acid supplementation among elderly chronic kidney disease patients: a double-blinded randomized controlled trial","volume":"57","author":"Sunsandee","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.clnesp.2024.11.020","article-title":"Association between hypovitaminosis D and sarcopenic obesity in patients with chronic kidney disease stages 3 and 4","volume":"65","author":"Alvarez-Mejia","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/j.jrn.2024.11.002","article-title":"A comparison between severity-dependent protocol and fixed-dose regimen of oral vitamin D supplementation on correction of hypovitaminosis D among dialysis patients","volume":"35","author":"Jiampochaman","year":"2025","journal-title":"J Ren Nutr"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/gerona\/glx086","article-title":"Longitudinal associations between vitamin D metabolites and sarcopenia in older Australian men: the Concord health and aging in men project","volume":"73","author":"Hirani","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.3390\/nu14163438","article-title":"Testosterone deficiency as one of the major endocrine disorders in chronic kidney disease","volume":"14","author":"Romejko","year":"2022","journal-title":"Nutrients"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.24.176","article-title":"Pathophysiology and potential treatment of uremic sarcopenia","author":"Yang","year":"2025","journal-title":"Kidney Res Clin Pract"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1557988320917258","DOI":"10.1177\/1557988320917258","article-title":"Effects of testosterone treatment on quality of life in patients with chronic kidney disease","volume":"14","author":"Yeo","year":"2020","journal-title":"Am J Mens Health"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"100365","DOI":"10.1016\/j.jcte.2024.100365","article-title":"Testosterone deficiency and chronic kidney disease","volume":"37","author":"Zitzmann","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.3390\/nu14163444","article-title":"Testosterone replacement therapy in chronic kidney disease patients","volume":"14","author":"Skiba","year":"2022","journal-title":"Nutrients"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000504557","article-title":"Impact of serum bicarbonate levels on muscle mass and kidney function in pre-dialysis chronic kidney disease patients","volume":"51","author":"Kittiskulnam","year":"2020","journal-title":"Am J Nephrol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ackd.2022.05.002","article-title":"Importance of metabolic acidosis as a health risk in chronic kidney disease","volume":"29","author":"Vincent-Johnson","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/0971-4065.202404","article-title":"The relationship between metabolic acidosis and nutritional parameters in patients on hemodialysis","volume":"27","author":"Sajgure","year":"2017","journal-title":"Indian J Nephrol"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1042\/CS20220501","article-title":"Muscle mass, muscle strength and the renin-angiotensin system","volume":"138","author":"Takeshita","year":"2024","journal-title":"Clin Sci"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/j.jrn.2023.10.008","article-title":"The effect of antihypertensive therapy on skeletal muscle mass and bone mineral density in patients with end-stage kidney disease","volume":"34","author":"Hashimoto","year":"2024","journal-title":"J Ren Nutr"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/ijerph17051494","article-title":"Hyperlipidemia and statins use for the risk of new diagnosed sarcopenia in patients with chronic kidney: a population-based study","volume":"17","author":"Lin","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1038\/s41598-021-88438-7","article-title":"\u03b22-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice","volume":"11","author":"Higashihara","year":"2021","journal-title":"Sci Rep"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.acc.2021.09.006","article-title":"Myostatin: basic biology to clinical application","volume":"106","author":"Esposito","year":"2022","journal-title":"Adv Clin Chem"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00018-022-04408-w","article-title":"Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases","volume":"79","author":"Abati","year":"2022","journal-title":"Cell Mol Life Sci"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1699218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:46:42Z","timestamp":1762249602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1699218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":118,"alternative-id":["10.3389\/fnut.2025.1699218"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1699218","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1699218"}}